WASHINGTON — With the help of two chief executives, the debate over whether genetically engineered salmon should enter the U.S. food supply heated up Thursday ahead of a series of Food and Drug Administration meetings that kick off this weekend.
The head of the Massachusetts firm that plans to sell the modified fish spoke to reporters Thursday to answer questions ahead of the meetings, which will examine safety and labeling issues.
Meanwhile, the head of Vermont-based ice cream maker Ben & Jerry's was set to descend on Washington Thursday to fight plans for the altered fish.
AquaBounty Technologies Chief Executive Ronald Stotish on Thursday told reporters he's hopeful the FDA will approve the company's salmon for sale.
To read the rest of the story, please go to: Fox Business.